
Keywords: Diabetes mellitus; Cancer risk; Insulin; Antidiabetic drugs; ATP; adenosine triphosphate; BMI; body mass index; CI; confidence interval; DDDs; defined daily doses; DNA; deoxyribonucleic acid; DPP-4 inhibitors; dipeptidyl peptidase-4 inhibitors; Egr-1; ear